NCT00144599View on ClinicalTrials.gov

Study of MRA for Systemic Juvenile Idiopathic Arthritis (sJIA)

PHASE3CompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

May 31, 2004

Study Completion Date

October 31, 2005

Conditions
Systemic Juvenile Idiopathic Arthritis
Interventions
DRUG

MRA(Tocilizumab)

DRUG

placebo

Sponsors
All Listed Sponsors
lead

Chugai Pharmaceutical

INDUSTRY